miR-429 as biomarker for diagnosis, treatment and prognosis of cancers and its potential action mechanisms: A systematic literature review.
This article summarizes the associations between miR-429 and malignant tumors as well as potential action mechanisms. miR-429 has a potential to be used in the future as a biomarker for the diagnosis, treatment and prognosis of certain cancers.
PMID: 31884798 [PubMed - as supplied by publisher]
Source: Neoplasma - Category: Cancer & Oncology Authors: Guo CM, Liu SQ, Sun MZ Tags: Neoplasma Source Type: research
More News: Bladder Cancer | Bone Cancers | Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Cervical Cancer | Colorectal Cancer | Endometrial Cancer | Epithelial Cancer | Esophagus Cancer | Gastric (Stomach) Cancer | Gastroenterology | Hepatocellular Carcinoma | Kidney Cancer | Liver Cancer | Lung Cancer | Nasopharyngeal Cancer | Oral Cancer | Osteosarcoma | Ovarian Cancer | Ovaries | Pancreas | Pancreatic Cancer | Prostate Cancer | Renal Cell Carcinoma | Sarcomas | Skin Cancer | Soft Tissue Sarcoma | Squamous Cell Carcinoma